Proteomic Guided First-line Precision Treatment of Renal Clear Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Renal Cell Carcinoma
Related studies linked through entity extraction aliases.
CD70-targeted CAR-NKT Cells(CGC729) Therapy in the Renal Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE1
Head-to-head Comparison of Positron Nuclide Radio-labeled FAPI and 18F-FDG PET/CT in Patients With Malignant Tumors
- Status
- RECRUITING
- Phase
- NA
A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours
- Status
- RECRUITING
- Phase
- PHASE1
Low Pressure Versus Standard Pressure Pneumoperitoneum in Laparoscopic Nephrectomy
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Pucotenlimab Combined With Lenvatinib as a Neodjuvant Therapy for Non Clear Cell Renal Cell Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER)
- Status
- RECRUITING
- Phase
- NA
A Study of Participant Reported Preference for Subcutaneous Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) Over Intravenous Pembrolizumab (MK-3475) Formulation in Multiple Tumor Types (MK-3475A-F11)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Delving Into Participation Trends in Renal Cell Carcinoma Studies
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Milademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A Loss
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
PET/MR for Characterization of Renal Masses (RMs)
- Status
- RECRUITING
- Phase
- N/A
Moesin Expression in Clear Cell Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- N/A
Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
A Study of HS-10516 in Patients With Advanced Clear Cell Renal Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE1
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer Types
- Status
- TERMINATED
- Phase
- PHASE1
Multimodal Recurrence Scoring System for Stratifying Stage III Clear Cell Renal Cell Carcinoma of Receiving Adjuvant Treatment
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Vascular Toxicities of Immune ChecKpoint Inhibitors : From Bed to Benchside
- Status
- COMPLETED
- Phase
- NA
A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Molecular Residual Disease (MRD) Guided Adjuvant ThErapy in Renal Cell Carcinoma (RCC)
- Status
- RECRUITING
- Phase
- PHASE2